Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo

被引:66
作者
Brenchley, Jason M.
Ruff, Laura E.
Casazza, Joseph P.
Koup, Richard A.
Price, David A.
Douek, Daniel C.
机构
[1] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
基金
英国医学研究理事会;
关键词
D O I
10.1128/JVI.00070-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
CD4(+) T-cell help is essential for effective immune responses to viruses. In human immunodeficiency virus (HIV) infection, CD4(+) T cells specific for HIV are infected by the virus at higher frequencies than other memory CD4(+) T cells. Here, we demonstrate that HIV-specific CD4(+) T cells are barely detectable in most infected individuals and that the corresponding CD4(+) T cells exhibit an immature phenotype compared to both cytomegalovirus (CMV)-specific CD4(+) T cells and other memory CD4(+) T cells. However, in two individuals, we observed a rare and diametrically opposed pattern in which HIV-specific CD4(+) T-cell populations of large magnitude exhibited a terminally differentiated immunophenotype; these cells were not preferentially infected in vivo. Clonotypic analysis revealed that the HIV-specific CD4(+) T cells from these individuals were cross-reactive with CMV. Thus, preferential infection can be circumvented in the presence of cross-reactive CD4(+) T cells driven to maturity by coinfecting viral antigens, and this physical proximity rather than activation status per se is an important determinant of preferential infection based on antigen specificity. These data demonstrate that preferential infection reduces the life span of HIV-specific CD4(+) T cells in vivo and thereby compromises the generation of effective immune responses to the virus itself; further, this central feature in the pathophysiology of HIV infection can be influenced by the cross-reactivity of responding CD4(+) T cells.
引用
收藏
页码:6801 / 6809
页数:9
相关论文
共 45 条
  • [21] Private specificities of CD8 T cell responses control patterns of heterologous immunity
    Kim, SK
    Cornberg, M
    Wang, XZ
    Chen, HD
    Selin, LK
    Welsh, RM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (04) : 523 - 533
  • [22] LEGAC E, 1992, BLOOD, V79, P1746
  • [23] High-level HIV-1 viremia suppresses viral antigen-specific CD4+ T cell proliferation
    McNeil, AC
    Shupert, WL
    Iyasere, CA
    Hallahan, CW
    Mican, J
    Davey, RT
    Connors, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) : 13878 - 13883
  • [24] QUANTITATIVE-ANALYSIS OF CD4+ T-CELL FUNCTION IN THE COURSE OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - GRADUAL DECLINE OF BOTH NAIVE AND MEMORY ALLOREACTIVE T-CELLS
    MEYAARD, L
    OTTO, SA
    HOOIBRINK, B
    MIEDEMA, F
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) : 1947 - 1952
  • [25] Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression:: Reciprocal interferon-γ and interleukin-10 responses
    Ostrowski, MA
    Gu, JX
    Kovacs, C
    Freedman, J
    Luscher, MA
    MacDonald, KS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (10) : 1268 - 1278
  • [26] Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes
    Oxenius, A
    Price, DA
    Easterbrook, PJ
    O'Callaghan, CA
    Kelleher, AD
    Whelan, JA
    Sontag, G
    Sewell, AK
    Phillips, RE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) : 3382 - 3387
  • [27] HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA load
    Oxenius, A
    Price, DA
    Hersberger, M
    Schlaepfer, E
    Weber, R
    Weber, M
    Kundig, TM
    Böni, J
    Joller, H
    Phillips, RE
    Flepp, M
    Opravil, M
    Speck, RF
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (07) : 1199 - 1208
  • [28] HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
    Pitcher, CJ
    Quittner, C
    Peterson, DM
    Connors, M
    Koup, RA
    Maino, VC
    Picker, LJ
    [J]. NATURE MEDICINE, 1999, 5 (05) : 518 - 525
  • [29] Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3
    Plana, M
    Garcia, F
    Oxenius, A
    Ortiz, GM
    Lopez, A
    Cruceta, A
    Mestre, G
    Fumero, E
    Fagard, C
    Sambeat, MA
    Segura, F
    Miró, JM
    Arnedo, M
    Lopalcos, L
    Pumarola, T
    Hirschel, B
    Phillips, RE
    Nixon, DF
    Gallart, T
    Gatell, JM
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (03) : 791 - 799
  • [30] T cell receptor recognition motifs govern immune escape patterns in acute SIV infection
    Price, DA
    West, SM
    Betts, MR
    Ruff, LE
    Brenchley, JM
    Ambrozak, DR
    Edghill-Smith, Y
    Kuroda, MJ
    Bogdan, D
    Kunstman, K
    Letvin, NL
    Franchini, G
    Wolinsky, SM
    Koup, RA
    Douek, DC
    [J]. IMMUNITY, 2004, 21 (06) : 793 - 803